comparemela.com

Latest Breaking News On - Aerobiotix inc - Page 1 : comparemela.com

Hospital Air Purifiers Market Industry Report - Market Revenue Data for 2022, Estimates for 2023, Forecasts and CAGR Projections for 2024 through 2028

Aerobiotix Raises $25M Growth Equity Financing Led by Global Healthcare Investment Firm Vivo Capital

Patented Technology proven to KILL COVID-19

Patented Technology proven to KILL COVID-19 TORONTO, Jan. 25, 2021 ) AEROBIOVAC Canada is now exclusively distributing nationally the only Air Decontamination System (ADS) proven to KILL the SARS-CoV-2 (COVID-19) virus. The Patented AEROBIOTIX UVC Light technology has been clinically tested on live SARS-CoV-2 (COVID-19) aerosols and scientifically proven to KILL 100% of airborne viruses including SARS-CoV-2 (COVID-19) on a single pass through the Air Decontamination System (ADS). GermZone Air Decontamination Systems are currently being used in hospitals and medical facilities in the USA and around the globe.  “The hardest place to kill a pathogen is inside the human body. If we can eliminate the danger in the air before it gets a chance to enter the patient, the human and economic benefits are huge,” states David Kirschman, M.D., founder of Aerobiotix, Inc. “Real-time treatment and monitoring of air quality provides a new tool for infection prevention to ensure the mo

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.